Diagnostic workup of lung cancer.
Surg. Oncol. Clin. N. Am., Oct;20(4):667-79 (2011)
Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
AJR Am J Roentgenol., Feb;198(2):359-63 (2012)
Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery.
Clin J Am Soc Nephrol., Jul;7(7):1071-8 (2012)
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screenin
J. Thorac. Cardiovasc. Surg., Jul;144(1):25-32 (2012)
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.
J. Thorac. Cardiovasc. Surg., Jul;144(1):33-8 (2012)
Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes.
AJR Am J Roentgenol., Aug;195(2):W125-30 (2010)
Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens.
J. Thorac. Cardiovasc. Surg., Aug;140(2):352-5 (2010)
FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival.
Eur. J. Nucl. Med. Mol. Imaging., May;38(5):810-21 (2011)
Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.
Neoplasia., Jan;13(1):12-22 (2011)
Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro.
BMC Cancer., 11:169 (2011)
Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.
J. Natl. Cancer Inst., May;101(9):678-86 (2009)
Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.
J. Thorac. Cardiovasc. Surg., Aug;138(2):405-11 (2009)
Current trends in radiologic management of malignant pleural mesothelioma.
Semin. Thorac. Cardiovasc. Surg., 21(2):111-20 (2009)
Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
Semin. Thorac. Cardiovasc. Surg., 21(2):132-48 (2009)
Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.
J. Thorac. Cardiovasc. Surg., May;139(5):1233-40 (2010)
Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.
Cancer., Mar;116(6):1510-7 (2010)
Surgery for malignant pleural mesothelioma.
Expert Rev Respir Med., Jun;4(3):363-72 (2010)
Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma.
Semin. Thorac. Cardiovasc. Surg., 20(4):298-304 (2008)
Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.
Cancer., Mar;112(5):1106-13 (2008)
Transcriptome sequencing of malignant pleural mesothelioma tumors.
Proc. Natl. Acad. Sci. U.S.A., Mar;105(9):3521-6 (2008)
Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma.
Carcinogenesis., Aug;29(8):1555-9 (2008)
VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study.
Int J Surg., Apr;6(2):110-4 (2008)
Complications of extrapleural pneumonectomy.
Semin. Thorac. Cardiovasc. Surg., 19(4):355-9 (2007)
MR imaging of benign and malignant pleural disease.
Magn Reson Imaging Clin N Am., May;16(2):319-39, x (2008)
Modified T-tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforations.
Ann. Thorac. Surg., Mar;83(3):1129-33 (2007)
EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.
Clin. Cancer Res., Jul;14(13):4275-83 (2008)
Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Int J Surg., Aug;6(4):293-7 (2008)
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.
Br. J. Cancer., Jul;99(2):245-52 (2008)
Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.
Cancer., Oct;113(8):2129-38 (2008)
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
J. Clin. Oncol., Nov;26(31):5043-51 (2008)
Unusual case of hemoptysis 13 years after bilobectomy.
Ann. Thorac. Surg., Mar;83(3):1188-90 (2007)
Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.
J Thorac Oncol., Feb;1(2):175-6 (2006)
Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
Cancer Chemother. Pharmacol., Apr;61(4):549-58 (2008)
Primary Ewing sarcoma invading the heart: resection and reconstruction.
J. Thorac. Cardiovasc. Surg., Jun;133(6):1667-9 (2007)
Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy.
Int. J. Radiat. Oncol. Biol. Phys., Aug;68(5):1366-74 (2007)
Surgical interventions for emphysema.
Semin. Thorac. Cardiovasc. Surg., 19(2):157-71 (2007)
Morphologic and functional imaging of malignant pleural mesothelioma.
Eur J Radiol., Dec;64(3):356-66 (2007)
Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique.
J Vasc Interv Radiol., Sep;16(9):1257-62 (2005)
Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast.
J. Cell. Mol. Med., 9(3):662-9 (2005)
Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage.
Chest., Nov;128(5):3255-60 (2005)
Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation.
J. Thorac. Cardiovasc. Surg., Feb;131(2):438-46 (2006)
Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.
J. Clin. Oncol., Apr;24(10):1561-7 (2006)
Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935.
J Surg Oncol., Dec;94(7):599-606 (2006)
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors.
Cancer Res., Nov;66(21):10621-9 (2006)
Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
J. Pathol., Mar;211(4):447-54 (2007)
Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
J. Pathol., Mar;211(4):439-46 (2007)
Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement Program.
Ann. Thorac. Surg., Feb;83(2):425-31; discussion 432 (2007)
Innovative therapies: intraoperative intracavitary chemotherapy.
Thorac Surg Clin., Nov;14(4):549-56 (2004)
Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
AJR Am J Roentgenol., Feb;184(2):381-90 (2005)
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
J. Clin. Oncol., Mar;23(7):1530-7 (2005)
Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling.
Am. J. Pathol., Jun;166(6):1827-40 (2005)
Lung resection in patients with preoperative FEV1 < 35% predicted.
Chest., Jun;127(6):1984-90 (2005)
Validation of genomics-based prognostic tests in malignant pleural mesothelioma.
Clin. Cancer Res., Jun;11(12):4406-14 (2005)
Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling events.
J. Cell. Mol. Med., 9(2):387-97 (2005)
Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database.
Chest., Jul;128(1):237-45 (2005)
Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation.
Clin. Cancer Res., Mar;18(6):1568-77 (2012)
Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Eur J Cardiothorac Surg., Aug;40(2):298-303 (2011)
Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imaging.
J Magn Reson Imaging., Apr;33(4):968-73 (2011)
Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival.
Ann. Thorac. Surg., Oct;92(4):1202-7 (2011)
Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring.
Eur J Cardiothorac Surg., Apr;37(4):770-5 (2010)
Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing.
BMC Med. Genet., 10:149 (2009)
Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma.
Endocr Pract., Nov;14(8):1011-6 (2008)
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
Int. J. Radiat. Oncol. Biol. Phys., Jul;65(3):640-5 (2006)
Co-Author, "Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes."
American Journal of Roentgenology
Co-Author, "Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens."
The Journal of Thoracic and Cardiovascular Surgery
Co-Author, "Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma."
Co-Author, "Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases."
Co-Author, "Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring."
European Journal of Cardio-Thoracic Surgery
Co-Author, "Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma."
The Journal of Thoracic and Cardiovascular Surgery
Co-Author, "Permanent iodine-125 interstitial planar seed brachytherapy for close or positive margins for thoracic malignancies."
International Journal of Radiation Oncology Biology Physics
Co-Author, "Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery."
Co-Author, "Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study."
The Journal of Thoracic and Cardiovascular Surgery
Co-Author, "Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles."